Refereed Journal Publications & Reviews

2017

178. Douchez A., Billard E., Hèbert T. E., Chatenet D., Lubell W. D. “Design, Synthesis, and Biological Assessment of Biased Allosteric Modulation of the Urotensin II Receptor Using Achiral 1,3,4-Benzotriazepin-2-one Turn Mimics” J. Med. Chem., 2017, 60 (23), 9838–9859.

177. Possi K. C., Mulumba M., Omri S., Garcia-Ramos Y., Tahiri H., Chemtob S., Ong H., Lubell W. D. “Influences of Histidine-1 and Azaphenylalanine-4 on the Affinity, Anti-inflammatory, and Antiangiogenic Activities of Azapeptide Cluster of Differentiation 36 Receptor Modulators” J. Med. Chem., 2017, 60 (20), 9263–9274.

176. Atmuri, N. D. P.; Reilley, D. J.; Lubell, W. D. “Peptidomimetic Synthesis by Way of Diastereoselective Iodoacetoxylation and Transannular Amidation of 7–9-Membered Lactams.” Org. Lett. 2017, 19 (19), 5066-5069.

175. Strack, M.; Billard, E.; Chatenet, D.; Lubell, W.D. “Urotensin core mimics that modulate the biological activity of urotensin-II related peptide but not urotensin-II” Bioorg. Med. Chem. Lett. 2017, 27 (15), 3412-3416.

174. Gamberi, C.; Hipfner, D.R.; Trudel, M.; Lubell, W.D. “Bicaudal C mutation causes myc and TOR pathway up-regulation and polycystic kidney disease-like phenotypes in Drosophila.” PLoS Genet, 2017, 13 (4): e1006694.

173. Traoré, M.; Gignac, M.; Doan, N.-D.; Hof, F.; Lubell, W.D. "Aza-amino acid scanning of chromobox homolog 7 (CBX7) ligands" J. Pept. Sci. 2017, 23, 266-271.

172. Nadeau-Vallée, M.; Chin, P.-Y.; Belarbi, L.; Brien, M.-E.; Pundir, S.; Berryer, M.H.; Beaudry-Richard, A.; Madaan, A.; Sharkey, D.j.; Lupien-Meilleur, A.; Hou, X.; Quiniou, C.; Beaulac, A.; Boufaied, I.; Boudreault, A.; Carbonaro, A.; Doan, N.-D.; Joyal, J.-S.; Lubell, W.D.; Olson, D.M.; Robertson, S.A.; Girard, S.; Chemtob, S. "Antenatal Suppression of IL-1 Protects against Inflammation-Induced Fetal Injury and Improves Neonatal and Developmental Outcomes in Mice” J. Immunol. March 1, 2017, 198 (5) 2047-2062.

171. Zhang, J.; Mulumba, M.; Ong, H.; Lubell, W. D. “Diversity-Oriented Synthesis of Cyclic Azapeptides by A3-Macrocyclization Provides High-Affinity CD36-Modulating Peptidomimetics.” Angew. Chem. Int. Ed. 2017, 56 (22), 6284-6288

170. Chingle, R.; Proulx, C.; Lubell, W.D. “Azapeptide synthesis methods for expanding side chain diversity for biomedical applications” Acc. Chem. Res. 2017, 50, 1541–1556.